A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer

• Published in: Radiation oncology (London, England) Vol. 7; no. 1; p. 111
• Main Authors: Foroudi, Farshad, Wilson, Lesley, Bressel, Mathias, Haworth, Annette, Hornby, Colin, Pham, Daniel, Cramb, Jim, Gill, Suki, Tai, Keen Hun, Kron, Tomas
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 23-07-2012; BioMed Central; BMC
• Subjects: Bladder; Bladder cancer; Cancer; Cancer therapies; Care and treatment; Comparative analysis; Health aspects; Health physics; Humans; Imaging, Three-Dimensional; Intensity modulated radiation therapy; Medical equipment and supplies industry; Medical test kit industry; Muscle, Skeletal - pathology; Neoplasm Invasiveness; Radiation; Radiation dosimetry; Radiation therapy; Radiotherapy; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted - methods; Radiotherapy, Conformal - methods; Radiotherapy, Intensity-Modulated - methods; Retrospective Studies; Therapists; Therapy; Urinary Bladder Neoplasms - pathology; Urinary Bladder Neoplasms - radiotherapy; Volumetric modulated arc therapy; Australia; United States
• ISSN: 1748-717X; 1748-717X
• DOI: 10.1186/1748-717x-7-111

To compare 3 Dimensional Conformal radiotherapy (3D-CRT) with Intensity Modulated Radiotherapy (IMRT) with Volumetric-Modulated Arc Therapy (VMAT) for bladder cancer.
Radiotherapy plans for 15 patients with T2-T4N0M0 bladder cancer were prospectively developed for 3-DCRT, IMRT and VMAT using Varian Eclipse planning system. The same radiation therapist carried out all planning and the same clinical dosimetric constraints were used. 10 of the patients with well localised tumours had a simultaneous infield boost (SIB) of the primary tumour planned for both IMRT and VMAT. Tumour control probabilities and normal tissue complication probabilities were calculated.
Mean planning time for 3D-CRT, IMRT and VMAT was 30.0, 49.3, and 141.0 minutes respectively. The mean PTV conformity (CI) index for 3D-CRT was 1.32, for IMRT 1.05, and for VMAT 1.05. The PTV Homogeneity (HI) index was 0.080 for 3D-CRT, 0.073 for IMRT and 0.086 for VMAT. Tumour control and normal tissue complication probabilities were similar for 3D-CRT, IMRT and VMAT. The mean monitor units were 267 (range 250-293) for 3D-CRT; 824 (range 641-1083) for IMRT; and 403 (range 333-489) for VMAT (P < 0.05). Average treatment delivery time were 2:25min (range 2:01-3:09) for 3D-CRT; 4:39 (range 3:41-6:40) for IMRT; and 1:14 (range 1:13-1:14) for VMAT. In selected patients, the SIB did not result in a higher dose to small bowel or rectum.
VMAT is associated with similar dosimetric advantages as IMRT over 3D-CRT for muscle invasive bladder cancer. VMAT is associated with faster delivery times and less number of mean monitor units than IMRT. SIB is feasible in selected patients with localized tumours.